Predicting Mortality in Incident Dialysis Patients: An Analysis of the United Kingdom Renal Registry

被引:113
作者
Wagner, Martin [1 ,2 ]
Ansell, David [3 ]
Kent, David M. [4 ]
Griffith, John L. [5 ]
Naimark, David [6 ]
Wanner, Christoph
Tangri, Navdeep [2 ]
机构
[1] Univ Hosp Wurzburg, Zentrum Innere Med, Div Nephrol, Dept Med 1, D-97080 Wurzburg, Germany
[2] Tufts Med Ctr, Div Nephrol, Dept Med, Boston, MA USA
[3] Southmead Hosp, UK Renal Registry, Bristol, Avon, England
[4] Tufts Med Ctr, Ctr Predict Med Res, Boston, MA USA
[5] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Design & Data Resource Ctr, Boston, MA USA
[6] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Nephrol, Toronto, ON, Canada
基金
美国国家卫生研究院;
关键词
End-stage renal disease; predictive model; mortality; hemodialysis; peritoneal dialysis; CARDIOVASCULAR-DISEASE; RISK; SURVIVAL; COMORBIDITY; DEATH; REPLACEMENT; PERFORMANCE; POPULATION; MODEL;
D O I
10.1053/j.ajkd.2010.12.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The risk of death in dialysis patients is high, but varies significantly among patients. No prediction tool is used widely in current clinical practice. We aimed to predict long-term mortality in incident dialysis patients using easily obtainable variables. Study Design: Prospective nationwide multicenter cohort study in the United Kingdom (UK Renal Registry); models were developed using Cox proportional hazards. Setting & Participants: Patients initiating hemodialysis or peritoneal dialysis therapy in 2002-2004 who survived at least 3 months on dialysis treatment were followed up for 3 years. Analyses were restricted to participants for whom information for comorbid conditions and laboratory measurements were available (n = 5,447). The data set was divided into data sets for model development (n = 3,631; training) and validation (n = 1,816) using random selection. Predictors: Basic patient characteristics, comorbid conditions, and laboratory variables. Outcomes: All-cause mortality censored for kidney transplant, recovery of kidney function, and loss to follow-up. Results: In the training data set, 1,078 patients (29.7%) died within the observation period. The final model for the training data set included patient characteristics (age, race, primary kidney disease, and treatment modality), comorbid conditions (diabetes, history of cardiovascular disease, and smoking), and laboratory variables (hemoglobin, serum albumin, creatinine, and calcium levels); reached a C statistic of 0.75 (95% CI, 0.73-0.77); and could discriminate accurately among patients with low (6%), intermediate (19%), high (33%), and very high (59%) mortality risk. The model was applied further to the validation data set and achieved a C statistic of 0.73 (95% CI, 0.71-0.76). Limitations: Number of missing comorbidity data and lack of an external validation data set. Conclusions: Basic patient characteristics, comorbid conditions, and laboratory variables can predict 3-year mortality in incident dialysis patients with sufficient accuracy. Identification of subgroups of patients according to mortality risk can guide future research and subsequently target treatment decisions in individual patients. Am J Kidney Dis. 57(6): 894-902. (C) 2011 by the National Kidney Foundation, Inc.
引用
收藏
页码:894 / 902
页数:9
相关论文
共 35 条
[1]   A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients [J].
Adragao, T ;
Pires, A ;
Lucas, C ;
Birne, R ;
Magalhaes, L ;
Gonçalves, M ;
Negrao, AP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) :1480-1488
[2]  
[Anonymous], AM J KIDNEY DIS
[3]   Evolving Trends in Clinical Presentation of and Renal Replacement Therapy for Chronic Kidney Disease [J].
Ansell, David ;
Tomson, Charles R. V. .
NEPHRON CLINICAL PRACTICE, 2009, 111 (04) :C265-C267
[4]   Prediction of early death in end-stage renal disease patients starting dialysis [J].
Barrett, BJ ;
Parfrey, PS ;
Morgan, J ;
Barre, P ;
Fine, A ;
Goldstein, MB ;
Handa, SP ;
Jindal, KK ;
Kjellstrand, CM ;
Levin, A ;
Mandin, H ;
Muirhead, N ;
Richardson, RMA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (02) :214-222
[5]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[6]   Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients [J].
Drechsler, Christiane ;
Krane, Vera ;
Winkler, Karl ;
Dekker, Friedo W. ;
Wanner, Christoph .
KIDNEY INTERNATIONAL, 2009, 76 (05) :567-575
[7]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019
[8]   Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999 [J].
Foley, RN ;
Murray, AM ;
Li, SL ;
Herzog, CA ;
McBean, AM ;
Eggers, PW ;
Collins, AJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :489-495
[9]   The ERA-EDTA cohort study - comparison of methods to predict survival on renal replacement therapy [J].
Geddes, CC ;
van Dijk, PCW ;
McArthur, S ;
Metcalfe, W ;
Jager, KJ ;
Zwinderman, AH ;
Mooney, M ;
Fox, JG ;
Simpson, K .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) :945-956
[10]   Mortality among hemodialysis patients in Europe, Japan, and the United States:: Case-mix effects [J].
Goodkin, DA ;
Young, EW ;
Kurokawa, K ;
Prütz, KG ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (05) :S16-S21